Osimertinib After Amivantamab-Lazertinib–Associated Pneumonitis in EGFR-Mutant NSCLC: A Two-Case Report

JTO Clinical and Research Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles